Abstract
Myocardial infarction (MI) remains a major cause of morbidity and mortality worldwide. Rapid advances in the treatment of acute MI have significantly improved short-term outcomes in patients, due in large part to successes in preventing myocardial cell death and limiting infarct area during the time of ischemia and subsequent reperfusion. Matrix metalloproteases (MMPs) play key roles in post-MI cardiac remodeling and in the development of adverse outcomes. This review highlights the importance of MMPs in the injury and remodeling response of the left ventricle and also discusses their potential as therapeutic targets Additional pre-clinical and clinical research is needed to further investigate and understand the cardioprotective effects of MMPs inhibitors.
Keywords: Extracellular matrix, left ventricle, left ventricle remodeling, matrix metalloproteinases, myocardial infarction, Macrophage Infiltration, Polymorphonuclear Leukocyte Infiltration, Myofibroblast Activation, tissue inhibitors of metalloproteinases (TIMPs), Collagen
Current Drug Targets
Title:Matrix Metalloproteinases: Drug Targets for Myocardial Infarction
Volume: 14 Issue: 3
Author(s): Andriy Yabluchanskiy, Yaojun Li, Robert J. Chilton and Merry L. Lindsey
Affiliation:
Keywords: Extracellular matrix, left ventricle, left ventricle remodeling, matrix metalloproteinases, myocardial infarction, Macrophage Infiltration, Polymorphonuclear Leukocyte Infiltration, Myofibroblast Activation, tissue inhibitors of metalloproteinases (TIMPs), Collagen
Abstract: Myocardial infarction (MI) remains a major cause of morbidity and mortality worldwide. Rapid advances in the treatment of acute MI have significantly improved short-term outcomes in patients, due in large part to successes in preventing myocardial cell death and limiting infarct area during the time of ischemia and subsequent reperfusion. Matrix metalloproteases (MMPs) play key roles in post-MI cardiac remodeling and in the development of adverse outcomes. This review highlights the importance of MMPs in the injury and remodeling response of the left ventricle and also discusses their potential as therapeutic targets Additional pre-clinical and clinical research is needed to further investigate and understand the cardioprotective effects of MMPs inhibitors.
Export Options
About this article
Cite this article as:
Yabluchanskiy Andriy, Li Yaojun, J. Chilton Robert and L. Lindsey Merry, Matrix Metalloproteinases: Drug Targets for Myocardial Infarction, Current Drug Targets 2013; 14 (3) . https://dx.doi.org/10.2174/1389450111314030002
DOI https://dx.doi.org/10.2174/1389450111314030002 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Vitamin E in Oxidant Stress-Related Cardiovascular Pathologies: Focus on Experimental Studies
Current Pharmaceutical Design TRP Channels as A Newly Emerging Non-Voltage-Gated Ca2+ Entry Channel Superfamily
Current Pharmaceutical Design Molecular Imaging: Its Application In Cardiovascular Diagnosis
Current Pharmaceutical Design Lipoproteins, Stroke and Statins
Current Vascular Pharmacology A Review on the Phytochemicals, Ethnomedicine Uses and Pharmacology of Ficus Species
Current Traditional Medicine Endogenous Retroelements in Cellular Senescence and Related Pathogenic Processes: Promising Drug Targets in Age-Related Diseases
Current Drug Targets Patent Selections
Recent Patents on Cardiovascular Drug Discovery Prevalence of Dilated Cardiomyopathy in HIV-Infected African Patients Not Receiving HAART: A Multicenter, Observational, Prospective, Cohort Study in Rwanda
Current HIV Research The Future of Collateral Artery Research
Current Cardiology Reviews Homocysteine and Heart Failure: An Overview
Recent Patents on Cardiovascular Drug Discovery Glucagon-Like Peptide 1 and the Cardiovascular System
Current Diabetes Reviews Drug Uptake Systems in Liver and Kidney
Current Drug Metabolism Impact of RET Screening on the Management of Multiple Endocrine Neoplasia Type 2A: 10 Years Experience and Follow-Up in Three Families
Endocrine, Metabolic & Immune Disorders - Drug Targets Proteomics and Cardiovascular Disease: An Update
Current Medicinal Chemistry Remdesivir and Hydroxychloroquine: A Compassionate Use in Covid-19
Current Drug Targets Atrial Fibrillation with a Focus on Oral Antiarrhythmic Therapy
Current Drug Therapy Therapeutic Potential of Targeting Protease Activated Receptors in Cardiovascular Diseases
Current Pharmaceutical Design Cathinone Neurotoxicity (“The “3Ms”)
Current Neuropharmacology Noninvasive Diagnosis of Chemotherapy Related Cardiotoxicity
Current Cardiology Reviews The ErbB Receptors and their Ligands in Cancer: An Overview
Current Drug Targets